Press "Enter" to skip to content

Akorn reports record consolidated revenue of $73.

Akorn reports record consolidated revenue of $73 .9 million in first quarter 2013 Akorn, Inc. , a niche generic pharmaceutical company, today reported financial results because of its first quarter ended March 31, 2013. Raj Rai, CEO, commented, We are happy with our first one fourth results although we had been behind in the launches of certain products that were approved late this past year because of capacity constraints with our contract manufacturing partners in addition to market challenges. We expect resolution in the next half of the year sometime. We are also excited about the establishment of our new R&D center in Vernon Hills, Illinois.

Related StoriesNew vaccine applicant shows great promise at fighting respiratory syncytial virusCamels in Kenya infected by MERS virus, brand-new study findsCareFusion to display new respiratory solutions at AARC CongressResearchers conclude that study provides scientific evidence that wildfires, such as those that devastated a big part of the province of Valencia in 2012, affect the health of children, especially of those who are even more susceptible . Climate switch and public health Meanwhile, considering the predictions as regards climate modification that announce an increased risk of fires, according to the authors, it is very important that we identify the effects of forest fires on health and improve people's and managers' understanding of the problem, and also design public health strategies in order to protect both most vulnerable individuals and the rest of citizens .